The Sarah Cannon Transplant and Cellular Therapy Program at St. David’s South Austin (Texas) Medical Center and Dallas-based Texas Oncology have launched a clinical collaboration to deliver blood cancer and cellular therapy services.
The partnership establishes shared governance and coordinated clinical operations, and enables St. David’s South Austin Medical Center physicians to care for blood cancer and cellular therapy patients within Texas Oncology offices, according to an April 6 news release reviewed by Becker’s.
“The value-based enterprise includes clearly defined outcome measures centered on survival rates, response rates, timeliness of care, adherence to evidence-based treatment protocols and patient experience indicators,” the release said. “The joint governance board … will meet regularly to review performance data, identify opportunities for improvement and ensure accountability to the program’s mission.”
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
